Form 4 for TELA TELA Bio, Inc.
Accepted 2026-07-17 17:30:07 ET · period of report 2026-07-15 · accession 0001685640-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 17:30 | 2026-07-15 | TELA | Plovanic William J. | Dir | A - Grant | $0.785 | +20.9K | 44.5K | +89% | +$16.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-15 | A | A | 20,930 | $0.785 | 44,530 | D | — | — | (F1) Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested. |